XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/03/30/roches-subcutaneous-rituximab-gets-unanimous-recommendation-from-fda-advisory-committee/20%Monthly2018-01-09 18:16
https://www.bigmoleculewatch.com/2017/03/30/abbvies-humira-is-the-first-to-receive-fda-approval-for-fingernail-psoriasis/20%Monthly2018-01-09 18:15
https://www.bigmoleculewatch.com/2017/03/30/eleven-professors-file-amicus-brief-in-sandoz-v-amgen/20%Monthly2018-06-04 14:30
https://www.bigmoleculewatch.com/2017/03/30/alteogen-reportedly-transferring-biosimilar-to-qilu-pharmaceutical/20%Monthly2018-01-09 18:24
https://www.bigmoleculewatch.com/2017/03/29/fda-approves-genentechs-ocrevus-ocrelizumab/20%Monthly2018-01-09 18:26
https://www.bigmoleculewatch.com/2017/03/29/fda-approves-sanofi-and-regenerons-dupixent-dupilumab/20%Monthly2018-01-09 18:31
https://www.bigmoleculewatch.com/2017/03/28/biotechnology-innovation-organizations-amicus-brief-in-sandoz-v-amgen/20%Monthly2018-06-04 14:32
https://www.bigmoleculewatch.com/2017/03/27/celltrion-files-two-additional-petitions-for-ipr-of-genentechs-trastuzumab-patents/20%Monthly2018-01-09 18:34
https://www.bigmoleculewatch.com/2017/03/24/janssens-amicus-brief-sandoz-v-amgen/20%Monthly2018-06-04 14:33
https://www.bigmoleculewatch.com/2017/03/24/sanofi-and-regeneron-take-aim-on-amgen-il-4-receptor-patent/20%Monthly2018-01-09 18:37
https://www.bigmoleculewatch.com/2017/03/24/ec-approves-amgens-biosimilar-adalimumab/20%Monthly2018-01-09 18:45
https://www.bigmoleculewatch.com/2017/03/24/abbvie-files-amicus-brief-in-amgen-v-sandoz-supreme-court-case/20%Monthly2018-06-04 14:34
https://www.bigmoleculewatch.com/2017/03/22/celltrion-files-two-additional-petitions-for-ipr-on-genentechs-trastuzumab-patents/20%Monthly2018-01-09 18:46
https://www.bigmoleculewatch.com/2017/03/21/amgen-has-filed-for-eu-approval-for-herceptin-trastuzumab-biosimilar/20%Monthly2018-01-09 18:47
https://www.bigmoleculewatch.com/2017/03/17/celltrion-files-response-brief-in-inflixamab-appeal/20%Monthly2018-07-25 16:04
https://www.bigmoleculewatch.com/2017/03/17/celltrion-files-petitions-for-ipr-of-three-rituximab-patents/20%Monthly2018-01-09 20:27
https://www.bigmoleculewatch.com/2017/03/17/ptab-institutes-ipr-of-genentechs-bevacizumab-patent/20%Monthly2018-01-09 21:02
https://www.bigmoleculewatch.com/2017/03/16/ptab-institutes-ipr-in-hospiras-challenge-to-genentechs-trastuzumab-patent/20%Monthly2018-01-09 21:03
https://www.bigmoleculewatch.com/2017/03/15/mylan-and-genentech-reach-settlement-on-cabilly-patent-ipr/20%Monthly2018-01-09 21:05
https://www.bigmoleculewatch.com/2017/03/14/summary-of-amgens-opening-and-responsive-brief-in-sandoz-v-amgen/20%Monthly2018-06-04 14:35
https://www.bigmoleculewatch.com/2017/03/13/mylan-obtains-global-license-to-trastuzumab-in-ipr-settlement/20%Monthly2018-01-09 21:06
https://www.bigmoleculewatch.com/2017/03/10/section-337-actions-at-the-itc-another-forum-for-pharma-and-biosimilars-litigation/20%Monthly2019-03-15 18:29
https://www.bigmoleculewatch.com/2017/03/09/ipr-tracker-mylan-and-genentech-settle-humanized-antibodies-iprs/20%Monthly2018-01-09 21:32
https://www.bigmoleculewatch.com/2017/03/09/update-janssen-v-celltrion-damages-in-biosimilar-cases/20%Monthly2018-07-25 16:06
https://www.bigmoleculewatch.com/2017/03/08/uk-court-invalidates-abbvie-humira-patents/20%Monthly2018-10-10 17:24
https://www.bigmoleculewatch.com/2017/03/08/fda-accepts-eculizumab-sbla/20%Monthly2018-01-09 21:38
https://www.bigmoleculewatch.com/2017/03/07/bpcia-appears-unaffected-by-proposed-new-healthcare-law/20%Monthly2017-03-07 21:17
https://www.bigmoleculewatch.com/2017/03/03/coherus-files-two-more-petitions-for-ipr-of-abbvies-619-humira-patent/20%Monthly2017-05-12 13:31
https://www.bigmoleculewatch.com/2017/03/03/coherus-announces-humira-biosimilar-pk-clinical-bioequivalence-results/20%Monthly2018-01-09 22:18
https://www.bigmoleculewatch.com/2017/03/02/first-biosimilar-in-oncology-truxima-granted-marketing-approval-in-european-union/20%Monthly2018-01-09 22:19
https://www.bigmoleculewatch.com/2017/03/02/delaware-district-court-dismisses-genentech-v-amgen/20%Monthly2018-07-25 16:07
https://www.bigmoleculewatch.com/2017/03/01/new-mexico-senate-passes-bill-allowing-automatic-substitution-of-interchangeable-biologics/20%Monthly2017-05-12 15:27